NPPA Fixes Retail Prices for 30 New Drug Formulations Including Vitamin D3 and Calcium
The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 new drug formulations, including Vitamin D3 oral solution, calcium and vitamin supplements, anti-diabetic, cardiovascular, and immunosuppressant medicines. Prices are set under the Drugs (Prices Control) Order, 2013, and exclude Goods and Services Tax. Key drugs include Vitamin D3 oral solution priced around Rs 14.91-19.91 per ml and calcium-vitamin tablets at Rs 19.78 per tablet. The NPPA uses market data to determine price caps to ensure affordability.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. Coverage leans balanced overall (Left 3%, Centre 95%, Right 2%). Overall sentiment is neutral (60/100). Lens Score 32/100 — low public interest.
Outlets analysed (first-hand measurement by TBN's Bias Engine):
- businessstandard— balanced framing, neutral sentiment
- news18— balanced framing, neutral sentiment
- thefinancialexpress— balanced framing, neutral sentiment
AI Analysis
The articles present a neutral governmental perspective focused on regulatory actions by the NPPA and the Ministry of Chemicals and Fertilisers. Coverage emphasizes official price control measures without political commentary or opposition viewpoints. The framing is administrative and policy-oriented, reflecting regulatory intent to manage drug affordability.
The tone across the articles is factual and neutral, focusing on the announcement of price caps without emotive language. The coverage highlights regulatory efforts to control drug costs, presenting the information as a standard policy update without positive or negative sentiment. There is no evident criticism or praise, maintaining an objective stance.
How 3 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.